Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/15/2005US20050277170 Bioassays for determining if an microorganism produces AmpC beta-lactamase; kits
12/15/2005US20050277169 Active microcosm: screening antimicrobial producing microorganisms
12/15/2005US20050277168 Apparatus and methods for scanning and producing biological specimen film strips
12/15/2005US20050277167 Prolyl 3-hydroxylases
12/15/2005US20050277166 Method for measuring polyamines in erythrocytes, diagnostic method and kit for measuring polyamines in erythrocytes
12/15/2005US20050277165 Novel treatment
12/15/2005US20050277164 Blood glucose tracking apparatus and methods
12/15/2005US20050277162 Detection and modulation of cancer stem cells
12/15/2005US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond
12/15/2005US20050277154 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
12/15/2005US20050277153 detecting the presence or absence of nucleotide sequence variants in a sample to obtained from mammals, to determine if the mammal is predisposed to cardiovscular disorders or cancer; medical diagnosis
12/15/2005US20050277152 Method for separation and purification of nucleic acid and unit for separation and purification of nucleic acid
12/15/2005US20050277151 NTR3, a novel member of the TNF- receptor supergene family
12/15/2005US20050277150 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
12/15/2005US20050277149 Pharmaceutically tractable secondary drug targets, methods of identification and their use in the creation of small molecule therapeutics
12/15/2005US20050277148 Method for preparing correlation diagram or multiple alignment among nucleic acid sequences and program thereof
12/15/2005US20050277147 Identifying chromosomal abnormalities in cells obtained from follicular fluid
12/15/2005US20050277146 Method of amplifying template DNA molecule using strand-displacing DNA polymerase capable of carrying out isothermal amplification
12/15/2005US20050277145 Apparatus with microtiter plate format for multiplexed arraying
12/15/2005US20050277143 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
12/15/2005US20050277142 Recombinant cell line for the detection of dioxin-like compounds based on the expression of luciferase gene
12/15/2005US20050277141 Process for analyzing a complex biological state of biosystem and support permitting its direct interpretation
12/15/2005US20050277140 diagnosing non-inflammatory chronic pelvic pain syndrome in a male subject by detecting Monocyte chemoattractant protein-1 (MCP-1) and Macrophage Inflammatory Proteins (MIP)
12/15/2005US20050277139 Methods and apparatus for the detection and validation of microRNAs
12/15/2005US20050277138 Reactive functional groups
12/15/2005US20050277137 Diagnosing pancreatic cell proliferative disorders via concentration of tumor marker antigen in blood; immunoassay
12/15/2005US20050277136 Rapid identification of Nocardia farcinica
12/15/2005US20050277134 Method for amplifying nucleic acid and analysis of single-nucleotide polymorphism using the same
12/15/2005US20050277133 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
12/15/2005US20050277132 Nematode GS-like sequences
12/15/2005US20050277131 Mass spectrometry-based identification of proteins
12/15/2005US20050277130 Removing aurintricarboxylic acid (ATA), a reverse transcriptase inhibitor, from a blood sample containing ATA and a chaotropic salt for nucleic acid extraction by using urea at a pH of about 8.0; high speed analysis by creating a fibrin aggregate to confine pathogens to facilitate pathogen DNA extraction
12/15/2005US20050277129 APOE genetic markers associated with age of onset of Alzheimer's disease
12/15/2005US20050277128 Using magnetic particles comprising immobilized messenger RNA sequences to generate sublibraries of preferential gene sequences
12/15/2005US20050277127 High-throughput method of DNA immunogen preparation and immunization
12/15/2005US20050277126 Cytokine receptor chain
12/15/2005US20050277125 High-density reaction chambers and methods of use
12/15/2005US20050277124 Cardiac conduction system cells and uses thereof
12/15/2005US20050277123 Variants of NEDD4L associated with hypertension and viral budding
12/15/2005US20050277122 Devices and methods for contacting fluid with a chemical array
12/15/2005US20050277121 Crude biological derivatives competent for nucleic acid detection
12/15/2005US20050277120 Novel DNA threading intercalators
12/15/2005US20050277119 Substituted azaporphyrins as fluorescence labels
12/15/2005US20050277118 Methods for identifying subjects at risk of melanoma and treatments thereof
12/15/2005US20050277117 Drug discovery method
12/15/2005US20050277116 Compositions and methods for the identification of protein interactions in vertebrate cells
12/15/2005US20050277115 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
12/15/2005US20050277114 genetic primers and probes comprising nucleotide sequences covalently linked to detectable labels; detection of RNA viruses
12/15/2005US20050277111 Measuring method using surface acoustic wave device, and surface acoustic wave device and biosensor device
12/15/2005US20050277109 Predictive assay for immune response
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276818 Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
12/15/2005US20050276757 Methods of using ZC1 and ZC3 kinase substrate phosphorylation as biomarkers
12/15/2005US20050276728 Integration of sample storage and sample management for life science
12/15/2005US20050274612 Hybridization detecting unit including an electrode having depression parts and DNA chip including the detecting unit
12/15/2005DE10227962B4 Grundkörper für einen Bio-Chip, Anordnung zum Auslesen und Vorrichtung zur Hybridisierung Base for a bio-chip device for reading and apparatus for hybridization
12/15/2005DE10221091B4 SECM zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen SECM for detecting nucleic acid oligomer hybridization events
12/15/2005DE102004026330A1 Verwendung einer Genveränderung im Humanen GNAQ-Gen zur Vorhersage von Erkrankungsrisiken, Krankheitsverläufen und zur Vorhersage des Ansprechens auf Krankheitstherapien Use of a gene in Human GNAQ gene for the prediction of disease risk, disease progression and prediction of response to treatments
12/15/2005DE102004025746A1 Parallel sequencing of nucleic acids by optical methods, by cyclic primer-matrix extension, using a solid phase with reduced non-specific binding of labeled components
12/15/2005DE102004025745A1 Surface of solid phase, useful for parallel, optical analysis of many nucleic acids, has reduced non-specific binding of labeled components
12/15/2005DE102004025224A1 Quantitative dermination of hydrogen sulfide in gases, e.g. for monitoring waste gases, using flow system with biosensor comprising sulfur-oxidizing bacteria immobilized on oxygen sensor and/or pH sensor
12/15/2005DE102004022263A1 Vorrichtung und Verfahren zum Nachweis von molekularen Wechselwirkungen Device and method for the detection of molecular interactions
12/15/2005CA2778894A1 Compounds for measuring nitroreductase enzyme activity
12/15/2005CA2776050A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2775594A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2572450A1 Methods and compositions involving microrna
12/15/2005CA2570156A1 Needle-free administration of felv vaccines
12/15/2005CA2569531A1 Identification of tumors
12/15/2005CA2569520A1 Egfr mutations
12/15/2005CA2569512A1 Recombinase polymerase amplification
12/15/2005CA2569502A1 Diagnosing or predicting the course of breast cancer
12/15/2005CA2569491A1 2'-nitrobenzyl-modified ribonucleotides
12/15/2005CA2569486A1 For the analysis of exclusive gene expression profile using a trace amount of sample
12/15/2005CA2569202A1 Multigene predictors of response to chemotherapy
12/15/2005CA2569196A1 Fcgr3a gebotype and methods for evaluating treatment response to non-depleting antibodies
12/15/2005CA2569100A1 Methods for identifying risk of breast cancer and treatment thereof
12/15/2005CA2569079A1 Methods of screening for cell proliferation or neoplastic disorders
12/15/2005CA2568998A1 Polypeptides having dna polymerase activity
12/15/2005CA2568967A1 Agents and methods for diagnosing stress
12/15/2005CA2568889A1 Oligonucleotides for cancer diagnosis
12/15/2005CA2568841A1 Method and device for rapid detection and quantitation of macro and micro matrices
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568780A1 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005CA2568755A1 A marker for prenatal diagnosis and monitoring
12/15/2005CA2568732A1 Methods for predicting and monitoring response to cancer therapy
12/15/2005CA2568729A1 Biomarkers for the prediction of responsiveness to clozapine treatment
12/15/2005CA2568499A1 Method of detecting cystic fibrosis associated mutations
12/15/2005CA2568413A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
12/15/2005CA2568405A1 Biomarkers for monitoring inhibition of impdh pathway
12/15/2005CA2568360A1 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
12/15/2005CA2567978A1 Compositions and methods for synthesizing cdna
12/15/2005CA2567973A1 Methods for identifying risk of breast cancer and treatments thereof
12/15/2005CA2567619A1 Hif prolyl hydroxylase activity assay
12/15/2005CA2567526A1 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2567293A1 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
12/15/2005CA2567116A1 Enhancing protein expression
1 ... 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 ... 3003